Presence of minimal residual disease (MRD) in acute myelogenous leukemia (AML) patients preallogeneic bone marrow transplantation (BMT) is associated with a lower relapse-free survival (RFS)

H. K. Holland, R. A. Brav, K. Otoole, J. T. Holden, P. O. Connaghan, L. T. Heffiier, E. K. Waller, E. F. Winton, A. M. Yeager

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Presence of minimal residual disease (MRD) in acute myelogenous leukemia (AML) patients preallogeneic bone marrow transplantation (BMT) is associated with a lower relapse-free survival (RFS)'. Together they form a unique fingerprint.

Medicine & Life Sciences